Dehydroepiandrosterone inhibits the expression of carcinogen‐activating enzymes in vivo

• Published in: International journal of cancer 2003-06, Vol.105 (3), p.321-325
• Main Authors: Ciolino, Henry, MacDonald, Chistopher, Memon, Omar, Dankwah, Maame, Chao Yeh, Grace
• Format: Article
• Language: English
• Subjects: Adjuvants, Immunologic - pharmacology; Animals; Anticarcinogenic Agents - pharmacology; Aryl Hydrocarbon Hydroxylases - biosynthesis; Biological and medical sciences; Blotting, Western; Body Weight - drug effects; Carcinogenesis, carcinogens and anticarcinogens; Chemical agents; Cytochrome P-450 CYP1A1 - biosynthesis; Cytochrome P-450 CYP1A1 - pharmacology; Cytochrome P-450 CYP1A2 - biosynthesis; Cytochrome P-450 CYP1B1; cytochrome P450 1A1/1A2; Dehydroepiandrosterone - pharmacology; DHEA; DMBA; Dose-Response Relationship, Drug; EROD; Female; Medical sciences; Microsomes - metabolism; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - metabolism; Tumors
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/ijc.11075

We investigated the effect of the steroid hormone dehydroepiandrosterone (DHEA) on the hepatic expression and activity of carcinogen‐activating enzymes, the cytochromes P450 (CYP) 1A1, 1A2 and 1B1, in Sprague‐Dawley rats. In animals fed DHEA at 200 or 400 mg/kg body weight every other day for 2 weeks prior to exposure to the aryl hydrocarbon dimethylbenz[a]anthracene (DMBA, 5 mg/kg), there was a dose‐dependent decrease in hepatic CYP activity, as measured by ethoxyresorufin‐O (EROD) assay, from 37.1 to 22.9 and 14.7 pmoles/min/10 μg microsomes, respectively. DHEA did not directly inhibit microsomal EROD activity, however, leading us to investigate its effects on enzyme expression. To test this, we examined protein and mRNA levels of the enzymes. Western blot for CYP1A1 and CYP1A2 showed that DHEA inhibited the increase in hepatic CYP1A1 and CYP1A2 enzyme levels that are normally induced by DMBA. DMBA‐induced increase in expression of CYP1A1, CYP1A2 and CYP1B1 mRNA was similarly blunted in DHEA‐treated animals. DHEA was also able to significantly reduce the basal expression of CYP1A1 and CYP1A2 but not of CYP1B1. These results indicate that DHEA regulates the expression and, hence, the activity of hepatic carcinogen‐activating enzymes in vivo, and this may be an important mechanism of its chemopreventive activity. Published 2003 Wiley‐Liss, Inc.